Press release CE-marked antibody tests expand EUROIMMUN’s comprehensive portfolio of laboratory products to support the analysis of the immune response to COVID-19 EUROIMMUN, a PerkinElmer, Inc. company, today announced the launch of two CE marked assays – the Anti-SARS-CoV-2 RBD…
Read more
Reliable and fast diagnostics of cervical cancer While HPV tests detect infections with HPV and thus allow drawing conclusions on the risk of developing cervical cancer, the GynTect® test can be used in a second step to clarify whether affected…
Read more
With its newly developed software platform “EUROLabPolaris” EUROIMMUN meets the demands in the increasingly globalised field of laboratory diagnostics by en…
Emerging infectious diseases is a term for new infectious diseases in humans that have either newly appeared in a population or have already existed but are rap…
It is becoming increasingly clear that not only antibodies against SARS-CoV-2 play a role in building immunity against the coronavirus. T cells, as part of t…
After a virtually non-existent flu season in 2020/2021 and with the revival of public life and the relaxation of social distancing measures, there is increasing…